Does Rallies show Form 4 insider transactions for ARXS?

Yes. Rallies tracks ARXS insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is ARXS research on Rallies investment advice?

No. Rallies provides research, data, and educational context for ARXS. It does not provide personalized investment advice.

ARXS (Arxis, Inc. Class A Common Stock) Stock Analysis - Insider Trades

Arxis, Inc. Class A Common Stock (ARXS) is a publicly traded the market company. As of May 21, 2026, ARXS trades at $34.72 with a market cap of $13.97B and a P/E ratio of 0.00. ARXS moved +1.26% today. Year to date, ARXS is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $33.15 to $39.45. Analyst consensus is strong buy with an average price target of $44.44. Rallies surfaces ARXS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading ARXS stock inside the company?

Recent ARXS insider activity includes Jankowski Ryan Anthony bought 4.46K, Badakhsh Azad Sid bought 36.00K, Sealfon Ross Bradley bought 12.50K, Oetgen Stephen Duane bought 25.00K, and ALLEN PATRICK E bought 10.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

ARXS Key Metrics

Key financial metrics for ARXS
Metric	Value
Price	$34.72
Market Cap	$13.97B
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.00%
52-Week High	$39.45
52-Week Low	$33.15
Volume	1
Avg Volume	0
Revenue (TTM)	$0
Net Income	$0
Gross Margin	0.00%

Recent ARXS Insider Trades

Jankowski Ryan Anthony bought 4.46K (~$124.99K) on Apr 17, 2026.
Badakhsh Azad Sid bought 36.00K (~$1.01M) on Apr 17, 2026.
Sealfon Ross Bradley bought 12.50K (~$350.00K) on Apr 17, 2026.
Oetgen Stephen Duane bought 25.00K (~$700.00K) on Apr 17, 2026.
ALLEN PATRICK E bought 10.00K (~$280.00K) on Apr 17, 2026.

Latest ARXS News

Analysts Issue Buy Ratings on Arxis Post-IPO Citing Propulsion Backlog — May 11, 2026
Arxis falls 6% as post-IPO volatility hits tightly held, low-float shares — Apr 26, 2026
Arxis drops 6% as post-IPO rally fades amid heavy new-float volatility — Apr 25, 2026
Arxis slides 3% as post-IPO volatility meets S-8 share overhang and new options trading — Apr 24, 2026
Arxis pops as newly public float stays tight after April IPO filings — Apr 23, 2026

ARXS Analyst Consensus

10 analysts cover ARXS: 0 strong buy, 9 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $44.44.

Common questions about ARXS

Who is trading ARXS stock inside the company?: Recent ARXS insider activity includes Jankowski Ryan Anthony bought 4.46K, Badakhsh Azad Sid bought 36.00K, Sealfon Ross Bradley bought 12.50K, Oetgen Stephen Duane bought 25.00K, and ALLEN PATRICK E bought 10.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for ARXS?: Yes. Rallies tracks ARXS insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is ARXS research on Rallies investment advice?: No. Rallies provides research, data, and educational context for ARXS. It does not provide personalized investment advice.